FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366090438> ?p ?o ?g. }

• W4366090438 abstract "Abstract Background KRAS mutations are fraught with the progression of colorectal cancer and resistance to chemotherapy. There are pathways such as extracellular regulated protein kinase 1/2 (ERK1/2) and Akt downstream and farnesylation and geranylgeranylation upstream that are activated upon mutated KRAS. Previous studies have shown that statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are effective to treat KRAS mutated colorectal cancer cells. Increased doses of oxaliplatin (L-OHP), a well-known alkylating chemotherapeutic drug, causes side effects such as peripheral neuropathy due to ERK1/2 activation in spinal cords. Hence, we examined the combinatorial therapeutic efficacy of statins and L-OHP to reduce colorectal cancer cell growth and abrogate neuropathy in mice. Methods Cell survival and confirmed apoptosis was assessed using WST-8 assay and Annexin V detection kit. Detection of phosphorylated and total proteins was analyzed the western blotting. Combined effect of simvastatin and L-OHP was examined the allograft mouse model and L-OHP-induced neuropathy was assessed using cold plate and von Frey filament test. Results In this study, we examined the effect of combining statins with L-OHP on induction of cell death in colorectal cancer cell lines and improvement of L-OHP-induced neuropathy in vivo . We demonstrated that combined administration with statins and L-OHP significantly induced apoptosis and elevated the sensitivity of KRAS-mutated colorectal cancer cells to L-OHP. In addition, simvastatin suppressed KRAS prenylation, thereby enhancing antitumor effect of L-OHP through downregulation of survivin, XIAP, Bcl-xL, and Bcl-2, and upregulation of p53 and PUMA via inhibition of nuclear factor of κB (NF-κB) and Akt activation, and induction of c-Jun N-terminal kinase (JNK) activation in KRAS-mutated colorectal cancer cells. Moreover, simvastatin enhanced the antitumor effects of L-OHP and suppressed L-OHP-induced neuropathy via ERK1/2 activation in vivo . Conclusion Therefore, statins may be therapeutically useful as adjuvants to L-OHP in KRAS-mutated colorectal cancer and may also be useful in the treatment of L-OHP-induced neuropathy." @default.
• W4366090438 created "2023-04-19" @default.
• W4366090438 creator A5011158695 @default.
• W4366090438 creator A5021097066 @default.
• W4366090438 creator A5034653736 @default.
• W4366090438 creator A5039005762 @default.
• W4366090438 creator A5041716174 @default.
• W4366090438 creator A5043487343 @default.
• W4366090438 creator A5053195155 @default.
• W4366090438 creator A5059349831 @default.
• W4366090438 creator A5073470102 @default.
• W4366090438 creator A5081637527 @default.
• W4366090438 date "2023-04-17" @default.
• W4366090438 modified "2023-09-27" @default.
• W4366090438 title "Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy" @default.
• W4366090438 cites W1920937245 @default.
• W4366090438 cites W1943068165 @default.
• W4366090438 cites W1951308530 @default.
• W4366090438 cites W1968832890 @default.
• W4366090438 cites W1978123764 @default.
• W4366090438 cites W1981465968 @default.
• W4366090438 cites W2004021162 @default.
• W4366090438 cites W2011665876 @default.
• W4366090438 cites W2015513164 @default.
• W4366090438 cites W2026441219 @default.
• W4366090438 cites W2036729494 @default.
• W4366090438 cites W2048945072 @default.
• W4366090438 cites W2049594890 @default.
• W4366090438 cites W2076512539 @default.
• W4366090438 cites W2091103707 @default.
• W4366090438 cites W2101198015 @default.
• W4366090438 cites W2101711738 @default.
• W4366090438 cites W2125756326 @default.
• W4366090438 cites W2138994529 @default.
• W4366090438 cites W2144425748 @default.
• W4366090438 cites W2161636334 @default.
• W4366090438 cites W2222395671 @default.
• W4366090438 cites W2239414584 @default.
• W4366090438 cites W2521246019 @default.
• W4366090438 cites W2547431297 @default.
• W4366090438 cites W2609639720 @default.
• W4366090438 cites W2613716330 @default.
• W4366090438 cites W2761913001 @default.
• W4366090438 cites W2766897464 @default.
• W4366090438 cites W2898093807 @default.
• W4366090438 cites W2901210080 @default.
• W4366090438 cites W2978418561 @default.
• W4366090438 cites W2984978333 @default.
• W4366090438 cites W2990768607 @default.
• W4366090438 cites W3111834135 @default.
• W4366090438 cites W3116165762 @default.
• W4366090438 cites W3132780506 @default.
• W4366090438 cites W3134180840 @default.
• W4366090438 cites W3155564883 @default.
• W4366090438 cites W3157291855 @default.
• W4366090438 cites W3159871226 @default.
• W4366090438 cites W3164195804 @default.
• W4366090438 cites W3198076830 @default.
• W4366090438 cites W3199205980 @default.
• W4366090438 cites W3202794981 @default.
• W4366090438 cites W4200161390 @default.
• W4366090438 doi "https://doi.org/10.1186/s12935-023-02884-z" @default.
• W4366090438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37069612" @default.
• W4366090438 hasPublicationYear "2023" @default.
• W4366090438 type Work @default.
• W4366090438 citedByCount "1" @default.
• W4366090438 countsByYear W43660904382023 @default.
• W4366090438 crossrefType "journal-article" @default.
• W4366090438 hasAuthorship W4366090438A5011158695 @default.
• W4366090438 hasAuthorship W4366090438A5021097066 @default.
• W4366090438 hasAuthorship W4366090438A5034653736 @default.
• W4366090438 hasAuthorship W4366090438A5039005762 @default.
• W4366090438 hasAuthorship W4366090438A5041716174 @default.
• W4366090438 hasAuthorship W4366090438A5043487343 @default.
• W4366090438 hasAuthorship W4366090438A5053195155 @default.
• W4366090438 hasAuthorship W4366090438A5059349831 @default.
• W4366090438 hasAuthorship W4366090438A5073470102 @default.
• W4366090438 hasAuthorship W4366090438A5081637527 @default.
• W4366090438 hasBestOaLocation W43660904381 @default.
• W4366090438 hasConcept C104317684 @default.
• W4366090438 hasConcept C121608353 @default.
• W4366090438 hasConcept C126322002 @default.
• W4366090438 hasConcept C127561419 @default.
• W4366090438 hasConcept C185592680 @default.
• W4366090438 hasConcept C190283241 @default.
• W4366090438 hasConcept C2775975398 @default.
• W4366090438 hasConcept C2780962732 @default.
• W4366090438 hasConcept C2781187634 @default.
• W4366090438 hasConcept C31573885 @default.
• W4366090438 hasConcept C33195913 @default.
• W4366090438 hasConcept C502942594 @default.
• W4366090438 hasConcept C526805850 @default.
• W4366090438 hasConcept C55493867 @default.
• W4366090438 hasConcept C71924100 @default.
• W4366090438 hasConcept C75217442 @default.
• W4366090438 hasConcept C98274493 @default.
• W4366090438 hasConcept C98424977 @default.
• W4366090438 hasConceptScore W4366090438C104317684 @default.
• W4366090438 hasConceptScore W4366090438C121608353 @default.
• W4366090438 hasConceptScore W4366090438C126322002 @default.

• next